Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :139
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7082    
    Printed186    
    Emailed0    
    PDF Downloaded775    
    Comments [Add]    
    Cited by others 24    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2007  |  Volume : 44  |  Issue : 1  |  Page : 1-5

Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus


1 Department of Surgical Oncology, Creighton University. Omaha, NE-68131, USA
2 Department of Pathology, Creighton University. Omaha, NE-68131, USA

Correspondence Address:
S C Burjonrappa
Department of Surgical Oncology, Creighton University. Omaha, NE-68131
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.31160

Rights and Permissions

Background: The molecular events that accompany the progression to adenocarcinoma (ADC) of the esophagus are poorly understood. Aberrant mucin receptor expression can contribute to increased cell growth and metastatic ability. Aim: The aim of this study was to establish a pattern for mucin (MUC) gene expression in the esophageal mucosa under normal and pathological conditions. Setting: University Hospital Cancer Center Laboratory. Archived tissue samples studied in a retrospective fashion. Materials And Methods: Tissue samples were obtained from the archives of patients with histological evidence of Barrett's esophagus (BE) progressing to ADC. Immunohistochemical analysis was performed using mouse monoclonal antibodies for MUC1, MUC2, MUC5AC, MUC6. Semiquantitative scoring of histological staining was performed using a linear scoring system: 0-staining absent; 1-staining in 0-25%; 2-staining in 25-50%; and 3-staining in 50-75% of the epithelium. The Binomial test was used to explore trends and differences in frequency of mucin expression along the pathological sequence. Results: Only mild superficial staining of MUC1 was seen in normal squamous epithelium. MUC1 and MUC2 were uniformly expressed in all samples (7/7) of BE and dysplasia ( P =0.008). MUC1 expression was upregulated (7/7) in progression to adenocarcinoma ( P =0.008). The secretory mucins, MUC5AC and MUC6 showed a decrease in expression with progression from BE to dysplasia to ADC ( P <0.05). Conclusions: Downregulation of MUC5AC and MUC6 decreases mucosal protection against gastric acid. Increasing MUC1 expression is associated with progression from dysplasia to ADC. Upregulation of MUC2 reflects intestinal metaplasia in BE.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow